We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.99B
AUM Growth
+$475M
Cap. Flow
-$113M
Cap. Flow %
-1.13%
Top 10 Hldgs %
8.79%
Holding
968
New
62
Increased
353
Reduced
363
Closed
57

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$25M
2
FCNCA icon
First Citizens BancShares
FCNCA
+$23.1M
3
NEWT icon
NewtekOne
NEWT
+$21.4M
4
AGO icon
Assured Guaranty
AGO
+$18.9M
5
TECH icon
Bio-Techne
TECH
+$18.7M

Sector Composition

Rank Sector Weight
1 Industrials 27.54%
2 Technology 18.26%
3 Consumer Discretionary 12.96%
4 Financials 12.6%
5 Materials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXFY icon
801
Expensify
EXFY
$178M
$771K 0.01%
+94,600
New +$842K
NUS icon
802
Nu Skin
NUS
$254M
$769K 0.01%
+19,559
New +$813K
SCHW
803
Charles Schwab
SCHW
$181B
$768K 0.01%
14,671
VSTO
804
DELISTED
Vista Outdoor Inc.
VSTO
$748K 0.01%
26,981
-289
-1% -$7.91K
HI
805
DELISTED
Hillenbrand
HI
$739K 0.01%
15,557
-15,574
-50% -$715K
MLNK
806
DELISTED
MeridianLink
MLNK
$731K 0.01%
42,275
+13,275
+46% +$214K
CHRS icon
807
Coherus Oncology
CHRS
$227M
$730K 0.01%
106,700
PSMT icon
808
Pricesmart
PSMT
$5.94B
$729K 0.01%
+10,203
New +$715K
LCUT icon
809
Lifetime Brands
LCUT
$192M
$701K 0.01%
119,294
FBP icon
810
First Bancorp
FBP
$4.4B
$700K 0.01%
61,300
+35,195
+135% +$463K
DLX icon
811
Deluxe
DLX
$1.19B
$695K 0.01%
43,440
CTV
812
DELISTED
Innovid Corp.
CTV
$690K 0.01%
+489,270
New +$894K
HCC icon
813
Warrior Met Coal
HCC
$4.25B
$684K 0.01%
18,639
-19,868
-52% -$735K
BELFA icon
814
Bel Fuse Inc Class A
BELFA
$2.98B
$683K 0.01%
18,805
MAGN
815
Magnera Corp
MAGN
$475M
$671K 0.01%
16,185
GAIA icon
816
Gaia
GAIA
$46.8M
$671K 0.01%
242,179
-13,550
-5% -$41K
FTDR icon
817
Frontdoor
FTDR
$5.16B
$670K 0.01%
24,034
-268
-1% -$7.08K
HGV icon
818
Hilton Grand Vacations
HGV
$3.64B
$666K 0.01%
+15,000
New +$679K
TBPH icon
819
Theravance Biopharma
TBPH
$873M
$640K 0.01%
59,009
INSE icon
820
Inspired Entertainment
INSE
$182M
$640K 0.01%
50,000
FF icon
821
Future Fuel
FF
$218M
$638K 0.01%
86,490
-75,467
-47% -$649K
DOUG icon
822
Douglas Elliman
DOUG
$155M
$635K 0.01%
214,277
-83,989
-28% -$335K
CPK icon
823
Chesapeake Utilities
CPK
$3.2B
$634K 0.01%
+4,951
New +$615K
SMLR
824
DELISTED
Semler Scientific
SMLR
$626K 0.01%
23,376
-69
-0.3% -$1.93K
THRN
825
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$620K 0.01%
+134,300
New +$591K

Similar funds

Royce & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Royce & Associates held 968 positions worth $9.99B, up 5% from $9.52B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Royce & Associates's Q1 2023 filing shows 62 new, 353 increased, 363 reduced and 57 closed positions. Its largest new stake was Innovex International: 284,752 shares worth $8.17M. The largest sale was Interparfums, an estimated $35.1M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q1 2023 buy was Innovex International: 284,752 shares worth $8.17M.
  • Royce & Associates added most to RB Global in Q1 2023, an estimated $25M increase.
  • Royce & Associates's biggest Q1 2023 reduction was Interparfums, cutting an estimated $35.1M.
  • Royce & Associates fully exited nVent Electric in Q1 2023, selling an estimated $7.89M.
  • Royce & Associates's ten largest holdings make up 8.8% of its $9.99B portfolio in Q1 2023.
  • Royce & Associates opened 62 new positions and closed 57 in Q1 2023.
  • Royce & Associates's portfolio value rose 5% quarter-over-quarter to $9.99B.

Based on Royce & Associates's 13F filing for Q1 2023, filed 4 May 2023.